SYK Stock Analysis: Buy, Sell, or Hold?
SYK - Stryker Corporation
$327.81
-1.64 (-0.50%)
âŧ
5d:
-1.17%
30d:
-0.74%
90d:
+3.58%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Jul 30, 2026
0d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Aug 7, 2026 at $339.03 · last confirmed Aug 21, 2026
Strength: 6.5/10
Get Alerted When SYK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: SYK is fairly priced but lacks strong directional signals. At -2.0% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: SYK is fairly priced but lacks strong directional signals. At -2.0% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$506.55
Based on 7.8% avg growth
INTRINSIC VALUE TODAY
$314.53
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SYK is currently trading at $327.81, which is considered slightly low relative to its 30-day fair value range of $323.23 to $344.82. The stock's valuation (Forward PE: 19.6) is in line with its historical norms (20.8). Remarkably, the market is currently pricing in an annual earnings decline of 2.0% over the next few years. This pessimistic expectation contrasts with the company's recent 44.1% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, SYK is in a uptrend. The price is currently testing key support at $324.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SYK scores 21/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $382.72 (+16.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SYK is in a uptrend. The price is currently testing key support at $324.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SYK scores 21/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $382.72 (+16.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$323.23 -
$344.82
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
54.8%
Protect Your Profits
Holding SYK? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (21/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($382.72)
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$323.23 -
$344.82
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$324.00
Resistance Level
$349.77
Current Trend
Uptrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.57
Wall Street Target
$382.72
(+16.8%)
Revenue Growth (YoY)
9.4%
Earnings Growth (YoY)
44.1%
Profit Margin
14.4%
Valuation Discount vs History
-2.0% cheaper
PE vs Historical
19.6 vs 20.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.0%
(market-implied from PE analysis)
1-Year Target
$321.25
(-2%)
2-Year Target
$314.83
(-4%)
3-Year Target
$308.53
(-6%)
3-Yr Target (if PE normalizes)
(PE: 20â21)
$328.01
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 11.6%)
$466.69
(+42%)
Base:
(SPY PE: 19.6, Growth: 11.6%)
$455.40
(+39%)
Bear:
(PE: 16.6, Growth: 11.6%)
$387.09
(+18%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (34x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 34.14 | Current EPS (TTM): $9.65
Bull Case
$629.21
(+92%)
Analyst growth 73.6%, PE expands to 37.6
Base Case
$572.01
(+75%)
Market implied 73.6%, PE stable at 34.1
Bear Case
$224.03
(-32%)
Severe decline -20.0%, PE contracts to 29.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.6 to 20.8
Stabilization Target:
$348.50
(+6.3%)
PE Expansion Potential:
+6.3%
Share & Embed Analysis
Last updated: August 25, 2026 5:06 AM ET
Data refreshes hourly during market hours. Next update: 6:06 AM
Data refreshes hourly during market hours. Next update: 6:06 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SYK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 46 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 60 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 44 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 54 HOLD |
|
GEHC
GE HealthCare TechnologiâĻ |
STRONG BUY
21 analysts |
$83 | 38 SELL |
Advanced SYK Option Strategies
Professional options setups generated by AI based on today's SYK price and gamma walls.
